Outpatient care of upper gastrointestinal hemorrhage not related to portal hypertension;Seguridad del control ambulatorio de la hemorragia digestiva alta no relacionada con hipertensión portal

Medicina Clinica

Volumn 114, Issue SUPPL. 2, 2000, Pages 68-73

  Almela, Pedro ^a   Benages, Adolfo ^a   Peiró, Salvador ^b   Grau, Francisco ^a   Mínguez, Miguel ^a   Pena, Andrés ^a   Pascual, Isabel ^a   Mora, Francisco ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Fund Inst de Invest Serv Salud   (Spain)

Author keywords

Outpatient care; Upper gastrointestinal hemorrhage

Indexed keywords

AMBULATORY CARE; ARTICLE; COHORT ANALYSIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITAL ADMISSION; HUMAN; MALE; MIDDLE AGED; PORTAL HYPERTENSION; PROSPECTIVE STUDY; RISK FACTOR; SPAIN; STANDARD;

AMBULATORY CARE; COHORT STUDIES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; MALE; MIDDLE AGED; PATIENT ADMISSION; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN;

EID: 0033654797     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Rockall TA, Logan RFA, Devlin NB, Northfield TC. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Br Med J 1995; 311: 222-226.
2. Miño Fugarolas G, Jaramillo Esteban JL, Gálvez Calderón C, Carmona Ibáñez C, Reyes López A, De la Mata García M. Análisis de una serie general prospectiva de 3270 hemorragias digestivas allas. Rev Esp Enf Digest 1992; 82: 7-15.
3. Sugawa C, Steffes CP, Nakamura R, Sferra JJ, Sferra CS, Sugimura Y et al. Upper gastrointestinal bleeding in an urban hospital. Etiology, recurrence and prognosis. Ann Surg 1990; 212: 521-526.
4. Rockall TA, Logan RFA, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996; 38: 316-321.
5. Clason AE, Macleod DAD, Elton RA. Clinical factors in the prediction of further haemorrhage or mortality in accute upper gastrointestinal haemorrhage. Br J Surg 1986; 73: 985-987.
6. Katschinski B, Logan R, Davies J, Faulkner G, Pearson J, Langman M. Prognostic factors in upper gastrointestinal bleeding. Dig Dis Sci 1994; 39: 706-712.
7. Rockall TA, Logan RFA, Devlin HB, Nothfield TC. Variation in outcome after acute upper gastrointestinal haemorrhage. Lancet 1995; 346: 346-350.
8. Dombal FT, Clarke JR, Clamp SE, Malizia G, Kotwal MR, Morgan AG. Pronostic factors in upper gastrointestinal bleeding. Endoscopy 1986; 18: 6-10.
9. Turner IB, Jones M, Piper DW. Factors influencing mortality from bleeding peptic ulcers. Scand J Gastroenterol 1991; 26: 661-666.
10. Balanzó J, Villanueva C. Signes pronósticos en la hemorragia digestiva por ulcus péptico. Rev Esp Enf Digest 1991; 80: 386-389.
11. Stóltzing H, Ohmann C, Krick M, Thon K. Diagnostic emergency endoscopy in upper gastrointestinal bleeding. Do we have any decision aids for patient selection? Hepatogastroenterol 1991; 38: 224-227.
12. Oshita Y, Okazaki Y, Takemoto T, Kawai K. What are the signs of recent hemorrhage, and what do they mean? Criteria for massive bleeding. Endoscopy 1986; 18: 11-14.
13. Wara P. Endoscopy prediction of major rebleeding. A prospective study of stigmata of hemorrhage in bleeding ulcer. Gastroenterology 1985; 88: 1209-1214.
14. Laine L, Cohen H, Brodhead J, Cantor D, García F, Mosquera M. Prospective evaluation of immediate versus delayed refeeding and prognostic value of endoscopy in patients with upper gastrointestinal hemorrhage. Gastroenterology 1992; 102: 314-316.
15. Longstreth GF, Feitelberg SP. Outpatient care of selected patients with acute non-variceal upper gastrointestinal haemorrhage. Lancet 1995; 345: 108-111.
16. Harland R, Neilson D. Criteria for selective admission of patients with haematemesis. J R Soc Med 1992; 85: 26-28.
17. Packham CJ, Rockall TA, Logan RFA. Outpatient care for selected patients with acute upper gastrointestinal bleeding. Lancet 1995; 345: 659-660.
18. Walt RP. Preventing admissions for gastrointestinal bleeding. Lancet 1995; 345: 77-78.
19. Rockall TA, Logan RF, Devlin HB, Northfield TC, National Audit of Acute Upper Gastrointestinal Haemorrhage. Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. Lancet 1996; 347: 1138-1140.
20. Rutgeerts P, Vantrappen G. The benefits of endoscopy in upper gastrointestinal bleeding. Endoscopy 1986; 18: 15-17.
21. Díez A, Armengol JR, Salord J, Asbert JM, González-Pinto Y, Simón G. Evolución de las lesiones gástricas agudas hemorrágicas por fármacos. Med Clin (Barc) 1983; 80: 254-257.
22. Sánchez F, García JA, Molina M, Candel MF, Pérez JM. El síndrome de Mallory-Weiss como factor etiológico en la hemorragia digestiva alla. Revisión de 142 casos. Rev Esp Enf Dig 1990; 78: 197-200.
23. Zimmerman J, Meroz Y, Siguencia J, Tsvang E, Arnon R. Upper gastrointestinal hemorrhage. Comparision of the causes and prognosis in primary and secondary bleeders. Scand J Gastroenterol 1994; 29: 795-798.
24. Leivonen M, Kivilaakso E. Peptic ulcer bleeding today: risk factors and characteristics of the disease. Scand J Gastroenterol 1991; 26: 1013-1019.
25. Holvoet J, Terriere L, Van Hee W, Verbist L, Fierens E, Hautekeete ML. Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study. Gut 1991; 32: 730-734.
26. García Rodríguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 769-772.
27. Savage RL, Moller PW, Ballantyne CL, Wells JE. Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy. Arthritis Rheum 1993; 36: 84-90.
28. Laporte JR, Carné X, Vidal X, Moreno V, Juan J. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Lancet 1991; 337: 85-89.
29. Langman MSJ, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RFA et al. Risk of bleeding peptic ulcer associated with individual nonsteroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-1078.
30. Blackstone MO. Hospital admission for low-risk acute upper gastrointestinal bleeding. Lancet 1996; 347: 1130.
31. Laupacis A, Sackett DL, Roberts RS, An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988; 318: 1728-1733.
32. Moses LE. Measuring effects without randomized trials? Options, problems, challenges. Med Care 1995; 33: AS8-14.
33. Epstein AM. The outcomes movement-will it get us where we want to go? N Engl J Med 1990; 323: 266-270.
34. McPherson K. The Cochrane Lecture. The best and the enemy of the good: randomised controlled trials, uncertainty, and assessing the role of patient choice in medical decision making. J Epidemiol Community Health 1994; 48: 6-15.
35. D'Agostino RB, Kwan H. Measuring effectiveness. What to expect without a randomized control group. Med Care 1995; 33: AS95-105.
36. Greenfield S. The state of outcome research: are we on target? N Engl J Med 1989; 320: 1142-1143.
37. Fowler FJ Jr, Cleary PD, Magaziner J, Patrick DL, Benjamin KL. Methodological issues in measuring patient-reported outcomes: the agenda of the Work Group on Outcomes Assessment. Med Care 1994; 32: JS65-76.
38. Salive ME, Mayfield JA, Weissman NW. Patient outcomes research teams and the Agency for Health Care Policy and Research. Health Serv Res 1990; 25: 697-708.
39. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Medicina basada en la evidencia. Cómo ejercer y enseñar la MBE. Madrid: Churchill Livingstone, 1997.
40. Hennekens CH, Buring JE. Epidemiology in medicine. Boston: Little, Brown and Company, 1987.
41. Ash AS, Shwartz M. Evaluating the performance of risk-adjustment methods: dichotomous measures. En: Iezzoni LI, editor. Risk adjustment methods for measuring helthcare outcomes. Chicago: Health Administration Press, 1997; 427-470.